Bartlett & Co Wealth Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
2,065
+484
+31% +$223K 0.01% 268
2026
Q1
$659K Hold
1,581
0.01% 310
2025
Q4
$888K Buy
1,581
+1,289
+441% +$732K 0.01% 274
2025
Q3
$150K Hold
292
﹤0.01% 489
2025
Q2
$91.6K Sell
292
-51
-15% -$15.3K ﹤0.01% 563
2025
Q1
$105K Buy
343
+51
+17% +$17.2K ﹤0.01% 539
2024
Q4
$97K Sell
292
-25
-8% -$8.48K ﹤0.01% 543
2024
Q3
$106K Buy
317
+22
+7% +$8.36K ﹤0.01% 537
2024
Q2
$121K Buy
295
+70
+31% +$27.7K ﹤0.01% 514
2024
Q1
$90.9K Buy
225
+50
+29% +$17.6K ﹤0.01% 575
2023
Q4
$54.4K Buy
175
+100
+133% +$27K ﹤0.01% 690
2023
Q3
$18.2K Hold
75
﹤0.01% 841
2023
Q2
$18K Hold
75
﹤0.01% 840
2023
Q1
$14.1K Hold
75
﹤0.01% 772
2022
Q4
$15.9K Hold
75
﹤0.01% 762
2022
Q3
$11.8K Hold
75
﹤0.01% 800
2022
Q2
$11.2K Hold
75
﹤0.01% 844
2022
Q1
$12.3K Buy
+75
New +$12.4K ﹤0.01% 803

Other funds holding MEDP

Bartlett & Co Wealth Management's MEDP Position: Q2 2026 in Review

Bartlett & Co Wealth Management increased its Medpace (MEDP) stake by 31% in Q2 2026, buying an estimated $223K and bringing the position to 2,065 shares worth $1.09M. The position accounts for 0.01% of the portfolio, ranked #268.

Bartlett & Co Wealth Management first reported a position in MEDP in Q1 2022 and has held it in 18 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Bartlett & Co Wealth Management held 2,065 shares of Medpace worth $1.09M as of Q2 2026.
  • Bartlett & Co Wealth Management bought 484 Medpace shares in Q2 2026, an estimated $223K.
  • Medpace made up 0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #268 holding.
  • Bartlett & Co Wealth Management first reported a position in Medpace in Q1 2022 and has held it in 18 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.